TigerTox: Biotechs continue to rein in R&D costs, focus on top prospects – FierceBiotech http://bit.ly/BiotechSpend2011 #in #pharma
TigerTox: @matthewherper Impossible to meet R&D timelines surrounded by constant chaos. Reorgs take years not months to fully implement. Go figure!
TigerTox: RT @newsreactions: Imaging technologies for #preclinical models of bone and joint disorders http://bit.ly/OsteoPreclinImaging #in #pharma
